1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Baseline characteristics and univariate analysis of development of CIN
AllCIN (n = 7, 8.8%)No CIN (n = 73, 91.2%)P Value
Age (yr)73.775.173.6.60
Pre-SCr1.110.991.12.67
Post-SCr1.161.391.14.15
Pre-eGFR55.660.855.1.44
Pre-eGFR <6060.0%42.9%61.6%.43
HTN71.3%85.7%69.9%.67
DM37.5%14.3%39.7%.25
CAD50.0%28.6%52.1%.43
Diuretic10.0%0%11.0%1.00
Prolonged CSR10.0%57.1%5.5%.001a
Re-administration3.4%14.3%2.7%.24
Contrast volume147.3 mL148.6 mL147.2 mL.86
Contrast ratio0.570.490.58.66
  • 

    a P < .001 on multivariate analysis (OR, 23.0; 95% CI, 3.8–143).